Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
RATIONALE: Collecting and storing samples of blood and tissue from family members of patients with cancer to test in the laboratory may help the study of cancer in the future.
PURPOSE: This clinical trial is collecting blood and tissue samples from family members of patients with pancreatic disease, pancreatic cancer, and melanoma.
|Familial Pancreatic Cancer||Other: biologic sample preservation procedure Other: medical chart review Other: survey administration|
|Study Design:||Observational Model: Family-Based
Time Perspective: Prospective
|Official Title:||Biospecimen Resource for Familial Pancreas Research, a Data and Tissue Registry (Also Known as a Bio-repository, Bio-bank, Data and Tissue Database, Data and Tissue Bank, Etc.) to Help Advance Research in Familial Pancreas Disease|
- Collection of familial data and biospecimens in a data and tissue repository for familial pancreas research [ Time Frame: baseline ]
Biospecimen Retention: Samples With DNA
|Study Start Date:||August 2002|
|Estimated Study Completion Date:||September 2022|
|Estimated Primary Completion Date:||September 2022 (Final data collection date for primary outcome measure)|
Other: biologic sample preservation procedure
- To collect clinical history, family history, and blood and/or tissue samples from family members of patients diagnosed with pancreatic diseases, pancreatic cancer, or melanoma.
- To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers.
OUTLINE: Study participants undergo collection of blood and/or tissue samples as well as survey data for inclusion in a familial data and tissue registry. Participants complete two baseline surveys regarding their personal, family, health, and environmental exposure histories and regarding their opinions on cancer and cancer screening. Patients also complete a follow-up survey at 1 year and undergo review of their medical records.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00835133
|Contact: Bridget Eversmanfirstname.lastname@example.org|
|Contact: Sarah Amundsonemail@example.com|
|United States, Minnesota|
|Mayo Clinic Cancer Center||Recruiting|
|Rochester, Minnesota, United States, 55905|
|Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623|
|Principal Investigator:||Gloria M. Petersen, PhD, FACMG||Mayo Clinic|